Simultanübersetzung im Plenum (d/f und f/d). Keine Simultanübersetzung in den Workshops. / Traduction simultanée dans la plénière (all/f et f/all). Pas de traduction simultanée dans les ateliers.

Online, per Zoom, 9:20 Uhr

Verschiedenste Umweltfaktoren beeinflussen unsere Gesundheit, sowohl positiv als auch negativ. Massnahmen für verbesserte Umweltbedingungen sind somit eine vorausschauende Gesundheitsförderung und können dadurch spezifische Gesundheitsrisiken reduzieren. Welche Chancen und Herausforderungen ergeben sich daraus für die Krebsprävention? Dazu lanciert das Forum einen Dialog an der Schnittstelle von Umwelt und Gesundheit. Ziel ist die Auseinandersetzung mit Grundlagen, Bedürfnissen und Möglichkeiten einer nutzbringenden umweltbewussten Krebsprävention ...

Interactive webinar to discuss opportunities for expanding the AOP community of trainers.

The same 1.5-hour webinar will take place at two different times:

• 23 Nov 2020, 17:00 CET (registration)
• 30 Nov 2020, 10:00 CET (registration)

Academic researchers, clinicans, industry and regulatory representatives will discuss how to improve development of efficient and predictive in vitro DNT methods, and their use in regulatory risk assessment.

Webinar for public health professionals and risk assessors.

The 90 minute webinar will present the results of the WHO Network project on Prioritization of Chemicals for Risk Assessment, including an inventory of available tools to identify priority chemicals. Tools will be described and discussed for potential use in developing countries. A comparison will be made to the OECD project on International Best Practices for Identification of Priorities within Chemicals Management Systems. See flyer for further information.

12 November 2020, 14:00-15:30 CET

For all who need to comply with REACH directives and assess chemical risks

This practice-oriented training intends to

• explain the REACH regulatory framework,
• become familiar with the modelling tools,
• provide an approach on how to select an appropriate tool for a given set of exposure conditions,
• better interpret results generated by exposure assessment models.

9 November 2020, 16:00 CET, via Zoom

Hildegard Doerenkamp, a lifelong animal lover, was active in supporting alternatives to animal testing since she first saw a televised interview with toxicology Professor Gerhard Zbinden in 1982. They combined their individual assets to form the Doerenkamp-Zbinden Foundation to support the 3Rs of alternatives (Reduction, Refinement, and Replacement) ...

Speakers: Franz Gruber (President, Doerenkamp-Zbinden Foundation), Marcel Leist (Konstanz), Thomas Hartung (Baltimore), Bass Blaauboer (Utrecht), Pierre Cosson (Geneva), Akbarsha Mohammad Abdulkader (Mahatma Gandhi-Doerenkamp Center, India).

The TEDD Annual Meeting 2020 is dedicated to cutting edge academic and industrial research. We focus on microphysiological systems (MPS) and its application in different fields, including research on the COVID-19 and the development of in vitro disease and infection models. The on-line event will not only provide presentations but also allow you to network. Each participant has an opportunity to matchmake and request virtual 1-1 meetings. Additionally, we provide the exhibitors with the possibility to present their services and take part in virtual exhibition sessions over the “lunch break”.

4 sessions sont prévues :
Session I : Perturbateurs neuroendocriniens et métaboliques : Où en est-on ?
Session II : Modèles d’études et risques de biais
Session III : Risques émergents & nouvelles approches
Session IV : Les PE dans les Projets européens

The Webinar aims to share experience and lessons learned from providing training in the field of chemical risk assessment and to inspire and support trainers including new trainers.

EPA will host its Second Annual Conference on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing virtually.

Agenda topics

• Implementation of Animal Testing Reduction at EPA
• State of the Science in Development of NAMs (Case Studies)
• Addressing Current Limitations in NAMs
• Developing Scientific Confidence in NAMs